Commodore Capital LP 13D/13G Filings for C4 Therapeutics, Inc. (CCCC)

Commodore Capital LP 13D and 13G filings for C4 Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
4:05 pm
Sale		 2024-09-30 13G C4 Therapeutics, Inc.
CCCC		 Commodore Capital LP 3,410,384
4.800%		 -389,616decrease
(-10.25%)		 Filing
2023-12-22
4:05 pm
Purchase		 2023-12-14 13G C4 Therapeutics, Inc.
CCCC		 Commodore Capital LP 3,800,000
7.700%		 3,800,000increase
(New Position)		 Filing